Vnitr Lek 2021, 67(3):e35-e40 | DOI: 10.36290/vnl.2021.050

COVID-19 patient care experience in the United Kingdom

Bashar Aldhoon
Oddělení kardiologie, Worcestershire Acute Hospitals NHS Trust, Worcester, Spojené království

In response to the COVID-19 pandemic many health care systems have attempted to reorganize healthcare workforce. Many doctors and nurses have been redeployed to acute care wards. In order to ensure the best quality of care it is essential for health professionals to stay updated on clinical studies and novel therapeutical approaches. Most patients with COVID-19 who become seriously unwell have an acute respiratory illness and about 14 % will require non-invasive respiratory support. This article aims at presenting some of the approaches in respiratory support and drug therapy. The overview of management is based on current guidelines and conclusions of several studies. The author is aware of the fact that the approach in COVID-19 management may change over time based on the current state of knowledge. It is worth mentioning that regardless its severity clinical symptoms associated with COVID-19 pneumonia may only be minor and thus regular monitoring on standard wards is required. The article refers to recent studies related to dexamethasone and remdesivir. The treatment with interleukin-6 receptor antagonists is also discussed. Finally, other drugs in treatment of COVID-19 patients are mentioned.

Keywords: COVID-19, dexamethasone, non-invasive ventilation, oxygenotherapy, remdesivir, tocilizumab.

Published: May 26, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Aldhoon B. COVID-19 patient care experience in the United Kingdom. Vnitr Lek. 2021;67(3):e35-40. doi: 10.36290/vnl.2021.050.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Shah S, Majmudar K, Stein A et al. Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization. Acad Emerg Med 2020; 27(8): 681-692. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323027/pdf/ACEM-9999-na.pdf Go to original source... Go to PubMed...
    2. Torjesen I. Covid-19: Patients to use pulse oximetry at home to spot deterioration. BMJ 2020; 371: m4151. Dostupné z https://www.bmj.com/content/bmj/371/bmj.m4151.full.pdf Go to original source...
    3. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA 2020; 323(15): 1499-1500. Dostupné z https://jamanetwork.com/journals/jama/fullarticle/2762996. Go to original source... Go to PubMed...
    4. Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092819/pdf/NEJMoa2002032.pdf. Go to original source... Go to PubMed...
    5. Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA 2020; 323(22): 2329-2330. Dostupné z https://jamanetwork.com/journals/jama/fullarticle/2765302. Go to original source... Go to PubMed...
    6. Archer SL, Sharp WW, Weir EK. Differentiating COVID-19 pneumonia from acute respiratory distress syndrome (ARDS) and high altitude pulmonary edema (HAPE): therapeutic implications. Circulation 2020; 142: 101-104. Dostupné z https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.120.047915. Go to original source... Go to PubMed...
    7. Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383(2): 120-128. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412750/pdf/nihms-1610775.pdf. Go to original source... Go to PubMed...
    8. Nightingale R, Nwosu N, Kutubudin F et al. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service. BMJ Open Respir Res 2020; 7(1): e000639. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337881/pdf/bmjresp-2020-000639.pdf. Go to original source... Go to PubMed...
    9. Oranger M, Gonzalez-Bermejo J, Dacosta-Noble P et al. Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study. Eur Respir J 2020; 56(2): 2001692. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241113/pdf/ERJ-01692-2020.pdf. Go to original source... Go to PubMed...
    10. Grieco DL, Menga LS, Cesarano M et al. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure The HENIVOT Randomized Clinical Trial. JAMA. doi:10.1001/jama.2021.4682 Published online March 25, 2021. Go to original source... Go to PubMed...
    11. Bamford P, Bentley A, Dean J et al. ICS guidance for prone positioning of the conscious COVID patient 2020. Intensive Care Society, 2020. Dostupné z https://emcrit.org/wp-content/uploads/2020/04/2020-04-12-Guidance-for-conscious-proning.pdf.
    12. Helms J, Tacquard C, Severac F et al. CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46: 1089-1098. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197634/pdf/134_2020_Article_6062.pdf. Go to original source... Go to PubMed...
    13. Pellicori P, Doolub G, Wong CM et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews 2021; Issue 3. Art. No.: CD013879. Dostupné z https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013879/epdf/full. Go to original source...
    14. Malbrain MLNG, Ho S, Wong A. Thoughts on COVID-19 from the International Fluid Academy. ICU Management & Practice 2020; 1: 80-85. Dostupné z https://healthmanagement.org/uploads/article_attachment/icu1-v20-thoughtsoncovid-19.pdf.
    15. RECOVERY Collaborative Group: Horby P, Lim WS, Emberson JR et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021; 384(8): 693-704. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/pdf/NEJMoa2021436.pdf Go to original source... Go to PubMed...
    16. Vimaleswaran KS, Forouhi NG, Khunti K. Vitamin D and covid-19. BMJ 2021; 372: n544. Dostupné z https://www.bmj.com/content/bmj/372/bmj.n544.full.pdf. Go to original source... Go to PubMed...
    17. Beigel JH, Tomashek KM, Dodd LE et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020; 383: 1813-1826. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262788/pdf/NEJMoa2007764.pdf. Go to original source... Go to PubMed...
    18. Mehta RM, Bansal S, Bysani S et al. A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis. Int J Infect Dis 2021; PII: S1201-9712(21)00178-8. Dostupné z https://www.sciencedirect.com/science/article/pii/S1201971221001788. Go to original source...
    19. REMAP-CAP Investigators, Gordon AC, Mouncey PR, et al. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N Engl J Med 2021 Feb 25:NEJMoa2100433. doi: 10.1056/NEJMoa2100433. Dostupné z https://www.nejm.org/doi/full/10.1056/NEJMoa2100433. Go to original source...
    20. RECOVERY Collaborative Group, Horby PW, Pessoa-Amorim G et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv. 2021; preprint. Dostupné z https://www.medrxiv.org/content/10.1101/2021.02.11.21249258v1.
    21. Chen P, Nirula A, Heller B et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med 2021; 384: 229-237. Dostupné z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646625/pdf/NEJMoa2029849.pdf. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.